SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-08-053111
Filing Date
2008-08-14
Accepted
2008-08-14 17:22:07
Documents
8
Period of Report
2008-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a08-15187_110q.htm 10-Q 932028
2 EX-10.30 a08-15187_1ex10d30.htm EX-10.30 69695
3 EX-10.31 a08-15187_1ex10d31.htm EX-10.31 40329
4 EX-10.32 a08-15187_1ex10d32.htm EX-10.32 438511
5 EX-31.1 a08-15187_1ex31d1.htm EX-31.1 13078
6 EX-31.2 a08-15187_1ex31d2.htm EX-31.2 12695
7 EX-32.1 a08-15187_1ex32d1.htm EX-32.1 5980
8 EX-32.2 a08-15187_1ex32d2.htm EX-32.2 5997
  Complete submission text file 0001104659-08-053111.txt   1519809
Mailing Address ONE PARK PLACE, SUITE 450 ANNAPOLIS MD 21401
Business Address ONE PARK PLACE, SUITE 450 ANNAPOLIS MD 21401 410 269 2600
PHARMATHENE, INC (Filer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32587 | Film No.: 081020520
SIC: 2834 Pharmaceutical Preparations